AI's Impact on Alphabet & Recursion
Business & Finance News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
AI Investment: Alphabets Strategic Play vs. Recursions High-Risk Bet
Alphabet, the search giant behind Google, is leveraging AI to boost user engagement and traffic, positioning itself ahead of rivals. Despite a recent stock dip, their AI tools in cloud services and subscriptions are driving potential sales growth. In contrast, Recursion Pharmaceuticals, a biotech using AI for drug development, is still in the early stages, with no approved products or phase three trials, and is bleeding cash. While Alphabet looks primed for market-beating returns, Recursion is a high-risk bet for the bold.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/b4b27a480ab44311